End of community-wide treatment linked to resurgence of parasitic worm infections in Malawi
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 07:16 ET (31-May-2026 11:16 GMT/UTC)
Researchers at Liverpool School of Tropical Medicine have found that stopping mass drug administration for Lymphatic Filariasis (LF) was associated with an increase in infections from other parasitic worms, threatening disease control efforts.
The study, published in PLOS Neglected Tropical Diseases, suggests that once wider community treatment programmes for LF ended, school-aged children were nearly twice as likely to be infected with the intestinal roundworm Ascaris lumbricoides.
The USC research team that recently identified the hormone-encoding gene GDF15 as a key driver of pregnancy sickness has identified 9 additional genes linked to its most severe form, hyperemesis gravidarum (HG). Six of these genes had not been previously linked to the condition. Growing evidence shows HG has a strong biological and genetic basis and can lead to severe malnourishment, putting both mother and baby at risk. In the largest genetic study of HG to date, researchers from the Keck School of Medicine of USC and their international collaborators conducted a genome-wide association study (GWAS) of 10,974 women with the condition and 461,461 controls across European, Asian, African and Latino ancestries. The findings, just published in Nature Genetics, offer new clues about the condition and new hope for those affected. The researchers identified 10 genes linked to HG—four previously identified and six new. The strongest link by far was to growth differentiation factor 15 (GDF15), a gene that produces a hormone of the same name, which rises sharply during pregnancy. The other genes identified relate to key pregnancy hormones, appetite and nausea, insulin and metabolism, how the brain learns and adapts, and certain pregnancy outcomes. The findings reveal new potential treatment targets and could possibly also help match existing medications to patients based on their genetic profiles. The research team also just received approval to launch a clinical trial of metformin, a widely used diabetes medicine that increases GDF15 levels. The study will test whether taking metformin before pregnancy can desensitize women to the hormone, potentially reducing nausea and vomiting or preventing HG in women who have had it before.
Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of KIO-301 in Nature Medicine. The publication adds clinical detail to a program aimed at restoring light responsiveness with a small molecule “photoswitch” in patients with the advanced inherited retinal disease, retinitis pigmentosa.
A recent study shows that assistance dogs do not only help people with practical tasks, but actively contribute to their care, based on mutual trust and continuous interpretation of each other.
An extensive register‑based study conducted in Finland has found an increase in severe mental health problems among some adolescents and young adults who have undergone medical gender reassignment (GR).
Researchers from The University of Osaka have shown that the MIC11 gene of Toxoplasma gondii is essential for the parasite to egress, or exit, the host cell, a key part of the lifecycle. Deletion of MIC11 caused parasites to be unable to permeabilize host cell membranes and prevented egress. This study identifies potential new therapeutic targets for human diseases caused by parasites, such as toxoplasmosis and malaria, which represent a major global health problem.
Aortic aneurysms are a life-threatening condition. Currently, no effective drug therapies are available to slow aneurysm progression. Nagoya University researchers in Japan found that clonal hematopoiesis is linked to aortic aneurysm progression and suggested that commonly used osteoporosis medications may help slow this process.
Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon Kwon (Department of Electrical and Computer Engineering, SNU) and Prof. Sang Wan Kim (Department of Endocrinology and Metabolism, Seoul National University College of Medicine and Boramae Medical Center) has discovered a new mechanism and drug combination strategy that can effectively treat osteoporosis, a representative disease of super-aging societies.
The research findings were published on April 2nd in Bone Research, a world-leading journal in the field of bone metabolism.